Methods of controlling gene expression and gene silencing

Details for Australian Patent Application No. 2001283970 (hide)

Owner Syngenta Participations AG Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research

Inventors Phillips, Kenneth Lyon; Meins Jr., Frederick; Glazov, Evgueni Alexandrovich; Budziszewski, Gregory Joseph; Levin, Joshua Zvi

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001283970

PCT Pub. Number WO02/10362

Priority 60/222,202 01.08.00 US

Filing date 30 July 2001

Wipo publication date 13 February 2002

Acceptance publication date 4 May 2006

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

C07K 14/415 (2006.01) Peptides having more than 20 amino acids - from plants

C12N 9/22 (2006.01) Enzymes, e.g. ligases (6.) - Ribonucleases

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

Event Publications

4 May 2006 Application Accepted

  Published as AU-B-2001283970

31 August 2006 Standard Patent Sealed

17 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001283971

2001283969